A Phase IIIb, randomized, multicenter, open-label trial of evaluating safety and efficacy with treatment of Atezolizumab and Bevacizumab as a novel alternative treatment method to TACE in intermediate stage liver cancer patients.

Category Primary study
Registry of TrialsClinical Trials Registry - India
Year 2024
This article has no abstract
Epistemonikos ID: b508c125f6768ed41c8002a625799e30d4c5b1a7
First added on: Apr 09, 2025